Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetic Testing), Product (Reagents, Instruments), by Technology (PCR, DNA Sequencing, NGS), End User (Hospital, Academic Laboratory), and by Region - Forecast to 2029

Request Sample Page

The global molecular diagnostics market size is estimated to be USD 10.52 billion in 2021 and is expected to witness a CAGR of 16.79% during the forecast period. Increase in geriatric population, introduction of technologically advanced products, and growing investments by governments and numerous organizations for R&D in molecular diagnostics. Also, the increasing demand for point-of-care facilities and growing prevalence of target diseases are the major factors driving the market. Presence of an unclear regulatory framework, the regulatory framework for approvals pose as major restrictive factors on pharmaceutical, biotechnology, and medical technology industries and high prices of molecular diagnostics tests are the major factors hindering the market growth.

Global Molecular Diagnostics Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Application

On the basis of application, the market is segmented into oncology, pharmacogenomics, infectious diseases, genetic testing, and other applications. Infectious disease testing segmented is expected to dominate the molecular diagnostics market in 2021. The major reason for growth is due to the relapse of infectious diseases, including new strains of multidrug-resistant TB, H1N1, and HIV. Oncology application segment is expected to be the fastest-growing segment during the forecast period this growth rate is due to factors such as the increasing prevalence of cancer and the growth of progressive diagnostic tests such as companion diagnostics.

By Product

On the basis of product, the market is segmented into instruments, reagents, and others. The reagents segment accounts for the largest market share of the market in 2021. This segment is also predicted to register the highest CAGR during the forecast period. The availability of wide range of reagents and kits, increasing use of reagents in different therapeutic areas, increase in basic research and commercial applications, are the major factors supporting the development of the reagents and kits market.

By Technology

On the basis of technology, the market is segmented into PCR, in situ hybridization, isothermal nucleic acid amplification technology, chips and microarrays, mass spectrometry, sequencing, transcription mediated amplification (TMA), and others. PCR segment accounted for the largest share of the market in 2021. This market is projected to grow at the fastest CAGR during the forecast period. The large share of the PCR segment is credited to the growing use of PCR in proteomics and genomics emergence of advanced technologies such as qRT-PCR.

Regional Insights

North America dominated the molecular diagnostics global market in 2021 and is projected to maintain its domination during the forecast period.  The reason for this market share is the growing GDP, increasing disposable income, developed healthcare infrastructure, and rising adoption of cutting-edge clinical laboratory technologies in this region. Asia Pacific segment is projected to grow at a fastest CAGR during the forecast period.

Competitor Insights

Some of the major companies in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Abbott Laboratories (U.S.), Grifols (Germany), Siemens Healthcare (Germany), Becton, Dickinson, and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Danaher Corporation (U.S.). Investment in R&D, strategic collaborations & acquisitions, novel product launches are some of the major strategies adopted by the leading players operating in the industry.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The molecular diagnostics market report is categorized into the following segments and subsegments:

Molecular Diagnostics Market, By Product (Revenue, 2021-2029, USD Billion)

  • Instruments
  • Reagents
  • Others

Molecular Diagnostics Market Size and Forecast, by Technology (Revenue, 2021-2029, USD Billion)

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization (ISH)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Transcription Mediated Amplification (TMA)
  • Others

Molecular Diagnostics Market Size and Forecast, by Application (Revenue, 2021-2029, USD Billion)

  • Oncology
    • Breast cancer
    • Cervical cancer
    • Prostate cancer
    • Colorectal cancer
    • Kidney cancer
    • Other cancers
  • Pharmacogenomics
  • Infectious Diseases
    • Respiratory Syncytial Virus (RSV)
    • Candida
    • Methicillin-Resistant Staphylococcus Aureus (MRSA)
    • Clostridium Difficile
    • Vancomycin-Resistant Enterococci (VRE)
    • Carbapenem-resistant bacteria
    • Flu
    • Tuberculosis (TB) and Drug-Resistant TBA
    • Meningitis
    • Others
  • Genetic Testing
    • Predictive and Presymptomatic testing
    • Newborn Screening
    • Other Genetic Testing
  • Others

Molecular Diagnostics Market, By Region (Revenue, 2021-2029, USD Billion)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Molecular Diagnostics Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Molecular Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Molecular Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Molecular Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product
    1. Instruments
      1. Instruments Market Forecast, 2021-2029 (USD Million)
    2. Reagents
      1. Reagents Market Forecast, 2021-2029 (USD Million)
    3. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Technology
    1. Polymerase Chain Reaction (PCR)
      1. Polymerase Chain Reaction (PCR) Market Forecast, 2021-2029 (USD Million)
    2. In Situ Hybridization (ISH)
      1. In Situ Hybridization (ISH) Market Forecast, 2021-2029 (USD Million)
    3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast, 2021-2029 (USD Million)
    4. Chips and Microarrays
      1. Chips and Microarrays Market Forecast, 2021-2029 (USD Million)
    5. Mass Spectrometry
      1. Mass Spectrometry Market Forecast, 2021-2029 (USD Million)
    6. Sequencing
      1. Sequencing Market Forecast, 2021-2029 (USD Million)
    7. Transcription Mediated Amplification (TMA)
      1. Transcription Mediated Amplification (TMA) Market Forecast, 2021-2029 (USD Million)
    8. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Oncology
      1. Oncology Market Forecast, 2021-2029 (USD Million)
    2. Pharmacogenomics
      1. Pharmacogenomics Market Forecast, 2021-2029 (USD Million)
    3. Infectious Diseases
      1. Infectious Diseases Market Forecast, 2021-2029 (USD Million)
    4. Genetic Testing
      1. Genetic Testing Market Forecast, 2021-2029 (USD Million)
    5. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Molecular Diagnostics Market
    1. North America Molecular Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
      2. S. Molecular Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
        2. Canada Molecular Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
  1. Europe Molecular Diagnostics Market
    1. Europe Molecular Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
      2. Germany Molecular Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
        2. UK Molecular Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
          2. France Molecular Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
            2. Spain Molecular Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
              2. Italy Molecular Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
                2. Rest of Europe Molecular Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
  1. Asia Pacific Molecular Diagnostics Market
    1. Asia Pacific Molecular Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
      2. Japan Molecular Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
        2. China Molecular Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
          2. India Molecular Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
            2. South Korea Molecular Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
              2. Australia Molecular Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                  3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Molecular Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                    3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
  1. Latin America Molecular Diagnostics Market
    1. Latin America Molecular Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
      2. Brazil Molecular Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
        2. Mexico Molecular Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
          2. Argentina Molecular Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
            2. Rest of Latin America Molecular Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
                3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
  1. MEA Molecular Diagnostics Market
    1. MEA Molecular Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
        3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
      2. GCC Molecular Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
          3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
        2. South Africa Molecular Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
            3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
          2. Rest of MEA Molecular Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Technology, 2021-2029 (USD Million)
              3. Market Size and Forecast byApplication, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Roche Diagnostics (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    2. QIAGEN N.V. (Netherlands)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    3. Hologic Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    4. Abbott Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    5. Grifols (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    6. Siemens Healthcare (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    7. Becton, Dickinson, and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    8. Beckman Coulter Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    9. bioMérieux SA (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    10. Danaher Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Technology Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports